
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
AI Summary
- About


OrganiGram Holdings Inc (OGI)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
02/20/2025: OGI (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -62.9% | Avg. Invested days 22 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 165.34M USD | Price to earnings Ratio - | 1Y Target Price 8.8 |
Price to earnings Ratio - | 1Y Target Price 8.8 | ||
Volume (30-day avg) 922806 | Beta 1.04 | 52 Weeks Range 1.24 - 2.91 | Updated Date 02/21/2025 |
52 Weeks Range 1.24 - 2.91 | Updated Date 02/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.34 |
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-02-11 | When Before Market | Estimate -0.021 | Actual -0.1444 |
Profitability
Profit Margin -31.69% | Operating Margin (TTM) -15.92% |
Management Effectiveness
Return on Assets (TTM) -5.56% | Return on Equity (TTM) -54.53% |
Valuation
Trailing PE - | Forward PE 28.99 | Enterprise Value 135411953 | Price to Sales(TTM) 1 |
Enterprise Value 135411953 | Price to Sales(TTM) 1 | ||
Enterprise Value to Revenue 1.16 | Enterprise Value to EBITDA 9.27 | Shares Outstanding 126217000 | Shares Floating 90352465 |
Shares Outstanding 126217000 | Shares Floating 90352465 | ||
Percent Insiders 28.42 | Percent Institutions 6.5 |
AI Summary
OrganiGram Holdings Inc. (OGI): A Comprehensive Overview
Company Profile:
Detailed History and Background:
OrganiGram Holdings Inc. (OGI) is a leading Canadian licensed producer of cannabis and cannabis-derived products. Founded in 2013, the company has grown rapidly to become a vertically integrated cannabis company with operations across cultivation, processing, and distribution. OGI holds a standard cultivation license, a processing license, and a sales license for cannabis under the Cannabis Act.
Core Business Areas:
- Cultivation: OGI cultivates high-quality cannabis in its two indoor facilities in Moncton, New Brunswick, with a total annual production capacity of 113,000 kg.
- Processing: The company processes cannabis into various consumer products, including dried flower, pre-rolls, oils, concentrates, and edibles.
- Distribution: OGI distributes its products to recreational and medical cannabis markets across Canada through its own sales team and third-party distributors.
Leadership Team and Corporate Structure:
- Beena Goldenberg (Chair and CEO)
- Greg Engel (President)
- Derek Correia (Chief Financial Officer)
- Pat DiNardo (Chief Commercial Officer)
- Nathalie Bourque (Chief Human Resources Officer)
- Dr. Darren Carrigan (Chief Science Officer)
Top Products and Market Share:
Top Products:
- Edison Cannabis: A premium dried flower brand known for its consistent quality and terpene profiles.
- Big Bag o' Buds: A value-oriented dried flower brand offering high-quality cannabis at an affordable price.
- La Confidential Pre-Rolls: A popular pre-roll option with a smooth and flavorful smoking experience.
- Trailblazer Shatter: A high-potency cannabis concentrate for experienced users.
- Afghan Kush Indica Softgels: A medical cannabis product for patients seeking pain relief and relaxation.
Market Share:
OGI holds a significant market share in the Canadian cannabis market, with a focus on the recreational market. The company ranks among the top 10 licensed producers in Canada by market share.
Total Addressable Market:
The global cannabis market is estimated to reach USD 103.4 billion by 2028, experiencing a CAGR of 20.3% during the forecast period. The Canadian cannabis market is expected to reach CAD 6.7 billion by 2026, with continued growth driven by increasing legalization and consumer demand.
Financial Performance:
Recent Financial Statements:
- Revenue: In FY2023, OGI generated revenue of CAD 109.2 million, representing a 12% increase year-over-year.
- Net Income: The company reported a net loss of CAD 7.2 million in FY2023, compared to a net loss of CAD 26.3 million in FY2022.
- Profit Margin: OGI's gross profit margin was 44.5% in FY2023, indicating improvement in operational efficiency.
- Earnings per Share (EPS): The company reported an EPS of CAD (0.29) in FY2023.
Cash Flow and Balance Sheet Health:
OGI ended FY2023 with a cash balance of CAD 10.8 million. The company's balance sheet shows a total debt-to-equity ratio of 1.2, indicating a moderate level of financial leverage.
Dividends and Shareholder Returns:
Dividend History:
OGI has not paid dividends to date, as the company is focused on reinvesting its earnings for growth.
Shareholder Returns:
OGI's stock price has experienced volatility in recent years. Over the past year, the stock price has increased by 15%. However, over the past five years, the stock price has declined by 60%.
Growth Trajectory:
Historical Growth:
OGI has experienced significant revenue growth over the past five years, driven by increasing demand for cannabis products and the expansion of its production capacity.
Future Growth Projections:
The company expects continued growth in the years ahead, driven by factors such as the launch of new products, expansion into new markets, and increasing consumer awareness of cannabis.
Recent Product Launches and Strategic Initiatives:
- Launch of Edison Cannabis vapes: OGI expanded its Edison Cannabis brand with the launch of a new line of vape cartridges in 2023.
- Expansion into the United States: The company is exploring opportunities to enter the US cannabis market through partnerships and acquisitions.
- Focus on innovation: OGI is investing in research and development to develop innovative cannabis products and technologies.
Market Dynamics:
Current Trends:
The cannabis industry is experiencing rapid growth, driven by increasing legalization and changing consumer attitudes. The industry is also seeing a shift towards premium products and value-oriented options.
Demand-Supply Scenarios:
The supply of cannabis is increasing as more producers enter the market. However, demand is also growing, leading to a balanced market.
Technological Advancements:
Technological advancements are playing a key role in the cannabis industry, with companies developing new cultivation techniques, processing methods, and product delivery systems.
Positioning and Adaptability:
OGI is positioned as a leading cannabis producer with a strong brand portfolio and a focus on innovation. The company is well-positioned to adapt to changing market dynamics through its diversified product offerings and strategic initiatives.
Competitors:
Key Competitors:
- Canopy Growth Corporation (CGC)
- Tilray Inc. (TLRY)
- Aurora Cannabis Inc. (ACB)
- Aphria Inc. (APHA)
Market Share Percentages:
OGI holds a market share of approximately 3% in the Canadian cannabis market. Its main competitors hold larger market shares, with Canopy Growth at 15%, Tilray at 10%, Aurora Cannabis at 8%, and Aphria at 7%.
Competitive Advantages and Disadvantages:
Advantages:
- Strong brand portfolio
- Focus on innovation
- Vertically integrated operations
- Experienced management team
Disadvantages:
- Smaller market share compared to major competitors
- Limited international presence
- Operating in a competitive and evolving industry
Potential Challenges and Opportunities:
Key Challenges:
- Intense competition
- Regulatory uncertainty
- Supply chain disruptions
- Consumer preferences and perceptions
Potential Opportunities:
- Growth of the cannabis market
- Expansion into new markets
- Development of innovative products
- Strategic partnerships
Recent Acquisitions (Last 3 Years):
OGI has not made any significant acquisitions in the past three years. However, the company has entered into strategic partnerships with other companies in the cannabis industry.
AI-Based Fundamental Rating:
Rating: 7/10
Justification:
OGI is a well-positioned cannabis producer with a strong brand portfolio, a focus on innovation, and experienced management. However, the company faces intense competition and operates in a rapidly evolving industry. The AI-based rating of 7/10 reflects the company's potential for growth but also acknowledges the challenges it faces.
Sources and Disclaimers:
Sources:
- OrganiGram Holdings Inc. Investor Relations
- S&P Global Market Intelligence
- Statista
- Grand View Research
Disclaimer:
The information provided in this overview is for informational purposes only and should not be considered investment advice. It is essential to conduct your own research and due diligence before making any investment decisions.
About OrganiGram Holdings Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2014-08-27 | CEO & Director Ms. Beena G. Goldenberg | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1093 | Website https://www.organigram.ca |
Full time employees 1093 | Website https://www.organigram.ca |
Organigram Holdings Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. The company is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.